市場調查報告書

皮膚癌治療領域 - 交易分析

Skin Cancers Therapeutics Area - Deals Analytics H2 2020 Report

出版商 GervanoRA Data Services LLP 商品編碼 968651
出版日期 內容資訊 英文 63 Pages
訂單完成後即時交付
價格
皮膚癌治療領域 - 交易分析 Skin Cancers Therapeutics Area - Deals Analytics H2 2020 Report
出版日期: 2020年11月04日內容資訊: 英文 63 Pages
簡介

本報告提供皮膚癌症治療領域調查分析,合作夥伴形勢的整體競爭相關的系統性資訊。

調查內容:

  • 交易類型為基礎的分析
  • 交易為基礎的分析:各金額
  • 交易以地區為基礎的分析
  • 交易廠商為基礎的分析
  • 每1年的分析
  • 交易頻率為基礎的分析
  • 運作中的交易企業為基礎的分析
  • 聯盟交易,金融交易,授權交易,著重了M&A交易的分析

目錄

第1章 皮膚癌症概要

  • 簡介
  • 治療流程、指南
  • 流行病學研究
    • 全球趨勢、歷史的趨勢

第2章 皮膚癌症的市場動態,競爭領域

  • 交易(合併/收購/聯盟)
    • 交易分析:各交易類型
    • 交易分析:各年度頻率
    • 交易分析:運作中的各企業
目錄

GervanoRA's 'Skin Cancers Therapeutics Areas - Deals Analytics H2 2020 Report' has analyzed and provided an understanding of the overall competition in partnering landscape in the disease area that has occurred from the year 2010.

GervanoRA has analyzed more than 681 drug candidates in the current development pipeline. Hence, a number of emerging and clinical-stage companies are embarking with collaborations or partnerships with different pharma companies to aid in the development process of their respective drug candidates. In the light of rocketing competition, not only companies, but also universities, institutes and research centers are getting actively involved in the advancements of new medicines for the treatment of the disease.

The report through its meticulous analysis on global therapeutic landscape of Skin Cancers Therapeutics Areas deals assists companies in taking future partnering decisions based on competitor's R&D activities; current trends in partnering landscape in order to avoid or mitigate competitive market risks.

For a proper understanding, GervanoRA has segmented the report into sections based on:

  • Analytics Based on Deal Type,
  • Analytics Based on Deal by Value,
  • Analytics Based on Deal Geography
  • Analytics Based on Deal Maker
  • Year-by-Year Analytics
  • Analytics Based on Deal Frequency
  • Analytics Based on Deal Active Player
  • Analytics Based on More Emphasis on Collaboration Deals, Financing Deals, Licensing Deals, Merger & Acquisition Deals.

The report also includes Brief over view on Skin Cancers and Skin Cancer Types, and Epidemiological Studies.

TABLE OF CONTENTS

CHAPTER 01: SKIN CANCERS OVERVIEW 4

  • 1.1. INTRODUCTION 4
  • 1.2. TREATMENT ALGORITHM AND GUIDELINES 7
  • 1.3. EPIDEMIOLOGY STUDIES 14
    • 1.3.1. GLOBAL AND HISTORICAL TRENDS 15
      • 1.3.1.1. UNITED STATES 17
      • 1.3.1.2. AUSTRALIA 18
      • 1.3.1.3. EUROPE 19

CHAPTER 02: MARKET DYNAMICS OF SKIN CANCERS COMPETITIVE SPACE 21

  • 2.1. DEALS (MERGERS/ ACQUISITIONS/ COLLABORATIONS) 21
    • 2.1.1 DEALS ANALYTICS BY DEAL TYPE 21
      • 2.1.1.1. COLLABORATION DEALS 22
      • 2.1.1.2. FINANCING DEALS 37
      • 2.1.1.3. LICENSING DEALS 43
      • 2.1.1.4. MERGER AND ACQUISITION DEALS 50
    • 2.1.2 DEALS ANALYTICS BY ANNUAL FREQUENCY 57
    • 2.1.3 DEALS ANALYTICS BY ACTIVEPLAYER 58